Targeting Strategies for Enhancing Paclitaxel Specificity in Chemotherapy

Paclitaxel (PTX) has been used for cancer treatment for decades and has become one of the most successful chemotherapeutics in the clinic and financially. However, serious problems with its use still exist, owing to its poor solubility and non-selective toxicity. With respect to these issues, recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yuan, Yu, Sifan, Ni, Shuaijian, Zhang, Baoxian, Kung, Angela Chun Fai, Gao, Jin, Lu, Aiping, Zhang, Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039396/
https://www.ncbi.nlm.nih.gov/pubmed/33855017
http://dx.doi.org/10.3389/fcell.2021.626910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039396/
https://www.ncbi.nlm.nih.gov/pubmed/33855017
http://dx.doi.org/10.3389/fcell.2021.626910

Ejemplares similares